X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 45 filers reported holding X4 PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,843 | -18.4% | 46,645 | +45.2% | 0.00% | – |
| Q2 2023 | $62,326 | +1038666.7% | 32,127 | +458857.1% | 0.00% | – |
| Q1 2023 | $6 | -33.3% | 7 | -22.2% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 9 | 0.0% | 0.00% | – |
| Q3 2022 | $15,000 | +66.7% | 9 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -96.8% | 9 | -94.4% | 0.00% | – |
| Q1 2022 | $280,000 | -56.0% | 160 | -42.4% | 0.00% | – |
| Q4 2021 | $637,000 | -59.2% | 278 | -5.8% | 0.00% | – |
| Q3 2021 | $1,561,000 | -48.0% | 295 | -36.1% | 0.00% | – |
| Q2 2021 | $3,003,000 | -93.8% | 462 | -91.8% | 0.00% | – |
| Q1 2021 | $48,293,000 | +142.1% | 5,609 | +80.8% | 0.00% | – |
| Q4 2020 | $19,946,000 | -18.2% | 3,102 | -13.9% | 0.00% | – |
| Q3 2020 | $24,392,000 | +332.6% | 3,603 | +495.5% | 0.00% | – |
| Q2 2020 | $5,639,000 | -87.9% | 605 | -87.0% | 0.00% | – |
| Q1 2020 | $46,520,000 | +159.6% | 4,652 | +177.7% | 0.00% | – |
| Q4 2019 | $17,922,000 | +33.0% | 1,675 | +58.0% | 0.00% | – |
| Q3 2019 | $13,473,000 | +772.0% | 1,060 | +929.1% | 0.00% | – |
| Q2 2019 | $1,545,000 | – | 103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |